NLE Perioperative & Pain Nursing — Pain ManagementStudy Notes

Pain is a complex, multidimensional subjective experience that serves as a protective mechanism. Understanding the physiologic mechanism of pain transmission helps nurses recognize why certain interventions work and how to select appropriate management strategies. The nociceptive pathway consists of four sequential processes: **1. Transduction** — The initial step occurs when a noxious stimulus (mechanical injury, thermal exposure, or chemical irritation) activates specialized sensory nerve endings called nociceptors. These receptors detect tissue-damaging stimuli and convert them into electrical nerve impulses. For example, when a patient undergoes surgical incision, mechanical trauma to tissues activates nociceptors in the surgical field, initiating the pain cascade. **2. Transmission** — The electrical impulse generated during transduction travels along peripheral nerves (A-delta fibers for sharp, immediate pain and C fibers for dull, burning, delayed pain) from the site of injury to the spinal cord. From the spinal cord, the signal ascends via the spinothalamic tract to the brain, particularly the thalamus and cortex. The speed of transmission varies: A-delta fibers conduct rapidly (producing the sharp pain you feel immediately upon injury), while C fibers conduct slowly (producing the sustained ache that follows). **3. Perception** — The brain becomes consciously aware of the pain when the signal reaches the cerebral cortex and thalamus. This is where pain becomes a conscious experience and where individual factors such as past experiences, cultural beliefs, emotional state, and expectations influence how the person interprets and experiences the pain. A postoperative patient's perception of pain, for instance, is shaped not only by the surgical trauma but also by their anxiety level, trust in their healthcare team, and previous surgical experiences. **4. Modulation** — The body has natural mechanisms to dampen or amplify pain signals through descending pathways from the brain to the spinal cord. The body produces endogenous opioids (endorphins and enkephalins) that bind to opioid receptors and reduce pain transmission. This is why relaxation, distraction, and emotional support can reduce pain perception—they activate these natural pain-suppressing mechanisms. **Gate Control Theory** — This influential theory, proposed by Melzack and Wall, provides the rationale for many non-pharmacologic pain interventions used in Philippine healthcare facilities. The theory suggests that the spinal cord acts as a "gate" that can be opened or closed by various mechanisms. Non-painful stimuli (such as rubbing, heat application, massage, or vibration) can "close the gate" at the spinal cord level, reducing the transmission of pain signals to the brain. This explains why mothers instinctively rub a child's bumped knee—the rubbing stimulates non-pain nerve fibers that inhibit pain transmission in the spinal cord. For nurses in Philippine hospitals and clinics, understanding gate control theory justifies the use of TENS (transcutaneous electrical nerve stimulation), massage, heat therapy, and comfort measures as legitimate pain management interventions that complement medication.

Nurses must differentiate between pain types because each type has distinct characteristics, underlying causes, and optimal management strategies. This classification system is essential for developing appropriate nursing care plans aligned with NANDA-I nursing diagnosis selection. **Acute Pain** — Acute pain is recent in onset and serves a protective, warning function by alerting the body to tissue injury or disease. Characteristics include: - Duration: typically under 3–6 months (or resolves when the underlying cause heals) - Onset: sudden or rapid - Physiologic responses: accompanied by sympathetic nervous system activation, producing visible signs such as tachycardia (elevated heart rate), tachypnea (rapid breathing), hypertension (elevated blood pressure), diaphoresis (sweating), pupil dilation, and pallor - Behavioral signs: guarding, restlessness, facial grimacing, and verbal expressions of distress - Associated emotions: anxiety, fear Examples include postoperative pain, trauma-related pain, acute myocardial infarction pain, and acute kidney stone pain. In Philippine healthcare settings, acute pain is commonly managed in post-operative recovery units, emergency departments, and acute medical wards. **Chronic (Persistent) Pain** — Chronic pain persists beyond the expected healing period, typically lasting longer than 3–6 months. Unlike acute pain, chronic pain often lacks the obvious physiologic warning signs and is frequently associated with significant psychosocial consequences. Characteristics include: - Duration: prolonged (more than 3–6 months), often indefinite - Physiologic responses: sympathetic responses may be absent or diminished because the body adapts; the patient may appear calm despite severe pain - Associated complications: depression, anxiety, fatigue, sleep disturbance, reduced physical activity, social isolation, and decreased quality of life - Functional impact: significant limitations in daily activities, work capacity, and social participation - Pain perception: influenced heavily by psychological, social, and environmental factors Examples include chronic back pain, chronic headaches, fibromyalgia, chronic arthritis, cancer pain, and neuropathic pain conditions. Managing chronic pain in the Philippine context often requires integration of services across primary health centers, specialty clinics, and community health services. **Nociceptive Pain** — Nociceptive pain results from stimulation of intact nociceptors by actual tissue damage. It is divided into two subcategories: *Somatic Nociceptive Pain* — Originates from skin, muscles, bones, and connective tissues. Characteristics: - Location: well-localized and easy to pinpoint - Quality: often described as aching, throbbing, sharp, or pressure-like - Response: typically responds well to NSAIDs and opioids - Examples: postoperative surgical incision pain, musculoskeletal injuries, fractures, burn pain *Visceral Nociceptive Pain* — Originates from internal organs (heart, lungs, abdomen, pelvis). Characteristics: - Location: poorly localized, deep, difficult to pinpoint; may be referred to distant locations (e.g., cardiac pain referred to the left arm) - Quality: often described as deep, cramping, squeezing, or pressure - Associated symptoms: may include nausea, vomiting, and sympathetic responses - Response: may require higher analgesic doses - Examples: abdominal pain from appendicitis, colicky pain from kidney stones, labor pain, cardiac ischemia pain **Neuropathic Pain** — Neuropathic pain arises from damage to or dysfunction of the nervous system itself, rather than from tissue damage. Characteristics: - Mechanism: results from injury, disease, or dysfunction of peripheral or central nerves - Quality: distinctive descriptors include burning, shooting, electric-shock-like, tingling, numbness, and "pins and needles" sensations - Location: often follows a dermatomal or nerve distribution pattern - Severity: can be severe and disabling - Response: often poorly responsive to NSAIDs and opioids alone; requires adjuvant medications like anticonvulsants (gabapentin, pregabalin) or antidepressants (amitriptyline, duloxetine) - Examples: diabetic peripheral neuropathy (very common in the Philippines given the high diabetes prevalence), post-herpetic neuralgia (pain following shingles), phantom limb pain (after amputation), spinal cord injury pain, chemotherapy-induced peripheral neuropathy, trigeminal neuralgia, postsurgical neuropathic pain In Philippine clinical practice, neuropathic pain management is increasingly important due to the rising prevalence of diabetes and its complications. Nurses must recognize neuropathic pain descriptors to facilitate appropriate referral and medication adjustments.

Accurate pain assessment is the foundation of effective pain management. The Philippine nursing standard and NLE expectations require nurses to systematically assess pain using structured approaches. Pain assessment must be documented as the "fifth vital sign" in all healthcare settings in the Philippines, consistent with WHO guidelines and The Joint Commission standards. **PQRST Framework for Pain Characterization** — This mnemonic helps nurses conduct a thorough pain history: **P — Provocation and Palliation** - Provocation: What causes or triggers the pain? What activities, movements, positions, or substances make it worse? - Palliation: What relieves or lessens the pain? What medications, positions, techniques, or environmental factors help? - Nursing relevance: Identifies pain triggers and effective interventions for individualized care planning - Documentation example: "Pain worsens with movement and deep breathing; improves with position change to semi-Fowler's and after receiving pain medication" **Q — Quality** - Describes the character or type of pain using the patient's own words - Common descriptors: sharp, dull, aching, throbbing, burning, shooting, electric, stabbing, cramping, pressure, squeezing, tight - Nursing relevance: Quality often indicates pain type (sharp and well-localized suggests somatic nociceptive; burning and shooting suggests neuropathic) - Documentation example: "Patient describes pain as sharp and throbbing in the surgical incision" **R — Region and Radiation** - Region: Where exactly is the pain located? Ask the patient to point or describe the anatomic location - Radiation: Does the pain travel or radiate to other areas? This is particularly important for visceral pain that may be referred - Nursing relevance: Localization helps assess whether pain is localized to the injury site or spreading (suggesting complications); radiation patterns help identify underlying causes - Documentation example: "Pain is localized to the right lower quadrant of the abdomen; no radiation noted" **S — Severity** - Objective measurement of pain intensity using a validated pain rating scale (see below) - Quantifies pain to monitor response to treatment over time - Nursing relevance: Enables objective documentation and comparison of pain levels before and after interventions - Documentation example: "Pain rated 8/10 on numeric rating scale before medication; reassessed at 30 minutes and rated 4/10" **T — Timing** - Onset: When did the pain begin? Suddenly or gradually? - Duration: How long does each pain episode last? - Pattern: Is it constant, intermittent, or does it follow a specific pattern? Does it have a predictable time of day when it worsens? - Frequency: How often does the pain occur? - Nursing relevance: Timing information helps identify pain patterns, anticipate breakthrough pain, and plan preventive interventions - Documentation example: "Pain began suddenly at 2 AM; currently constant and unrelieved; patient has not slept since onset" **Validated Pain Rating Scales** — The selection of an appropriate pain rating scale depends on the patient's age, cognition, and communication ability. Using validated tools ensures reliability and consistency of pain measurement across the healthcare team. **Numeric Rating Scale (NRS 0–10)** — The most commonly used and preferred scale in adult patients - Format: A 0–10 scale where 0 = no pain and 10 = the worst pain imaginable - Administration: Ask the patient: "On a scale of 0 to 10, where 0 is no pain and 10 is the worst pain you could imagine, how much pain are you in right now?" - Appropriate for: Adults and children 8 years and older who can understand number concepts - Advantages: Simple, quick, easily understood, facilitates communication across shifts - Documentation: Record both the pain rating and the time of assessment (e.g., "Pain NRS 7/10 at 10:15 AM") - Interpretation guide: 0 = no pain, 1–3 = mild pain, 4–6 = moderate pain, 7–9 = severe pain, 10 = worst imaginable pain **Wong-Baker FACES Pain Rating Scale** — Valuable for patients with communication barriers - Format: Series of 6 cartoon faces ranging from smiling (no pain) to crying/distressed (worst pain) - Each face is numbered from 0 to 10 (or 0–5 in some versions), with corresponding pain descriptors below - Appropriate for: Children ages 3 years and older, older adults, patients with cognitive impairment, non-English speakers, and those with hearing impairment - Administration: Show the patient the scale and ask, "Which face matches how much pain you have right now?" - Advantages: Transcends language barriers, uses universal expression of pain/comfort, engaging for pediatric patients - Cultural relevance: Widely used in Philippine healthcare settings and effective across diverse cultural groups **FLACC Scale (Face, Legs, Activity, Cry, Consolability)** — A behavioral pain assessment tool for nonverbal and preverbal patients - Appropriate for: Infants and children under 3 years old, mechanically ventilated patients, patients with severe cognitive impairment, and unconscious patients who cannot self-report pain - Components (each scored 0–2): - **Face**: 0 = no particular expression, 1 = occasional grimace/frown, 2 = frequent grimace/frown/clenched teeth - **Legs**: 0 = normal position, 1 = uneasy/restless/tense, 2 = kicking or legs drawn up - **Activity**: 0 = lying quietly/normal activity, 1 = squirming/shifting/tense, 2 = arched/rigid/jerking - **Cry**: 0 = no cry, 1 = moaning/whimpering, 2 = crying/screaming - **Consolability**: 0 = content/relaxed, 1 = reassured by touching/talking, 2 = difficult to console - Total score: 0–10 (add all component scores) - Interpretation: Scores of 4 or greater suggest significant pain and warrant intervention - Administration: Observe the patient for 2–5 minutes, then score based on observed behaviors - Advantages: Objective, systematic observation; evidence-based for nonverbal pain assessment **Other Behavioral/Observational Tools for Nonverbal Adults** — For cognitively impaired or sedated older adults, alternative scales include the Behavioral Pain Scale (BPS), Critical-Care Pain Observation Tool (CPOT), and Pain Assessment in Advanced Dementia (PAINAD), each scored based on observed facial expressions, body movements, muscle tension, and vocalization patterns. **Additional Pain Assessment Components** — Beyond intensity rating, comprehensive pain assessment in the Philippine nursing context includes: - Impact on function: How does pain affect sleep, appetite, ability to perform activities of daily living (ADLs), work, or social activities? - Emotional/psychological impact: Is the patient anxious, depressed, irritable, or experiencing altered coping? - Cultural factors: How does the patient's cultural background, beliefs, and family influence pain expression and management preferences? - Previous pain experiences: What pain management strategies have worked or not worked in the past? - Patient goals: What does the patient hope to achieve through pain management? Complete pain relief, or improved function? - Medications: Current analgesics and any known allergies or adverse effects **Reassessment After Intervention** — A critical nursing responsibility is to reassess pain after administering analgesics or implementing non-pharmacologic measures to evaluate effectiveness: - After oral medications: reassess 30–60 minutes post-administration - After IV medications: reassess 15–30 minutes post-administration - After non-pharmacologic interventions: reassess 15–30 minutes post-intervention - Document both the pain rating before and after intervention to objectively demonstrate the effectiveness of your nursing care - If pain relief is inadequate, notify the healthcare provider for medication adjustment or dose escalation

The World Health Organization (WHO) analgesic ladder is the gold standard framework for managing pain of all types, especially cancer pain and chronic pain conditions common in the Philippine healthcare setting. This stepwise approach ensures systematic, evidence-based medication selection and dosing. The ladder principle applies universally: start with the appropriate step based on pain severity, then progress upward as needed rather than jumping directly to strong opioids. **The Three-Step WHO Analgesic Ladder:** **Step 1: Mild Pain (Intensity 1–3/10)** — **Non-Opioid Analgesics ± Adjuvants** - Primary medications: Acetaminophen (paracetamol) and NSAIDs (nonsteroidal anti-inflammatory drugs) - Adjuvants: Medications from other drug classes added for specific pain types (especially neuropathic pain): antidepressants, anticonvulsants, topical agents, corticosteroids - Principle: Use non-opioids as first-line agents; they provide analgesia without the respiratory depression and addiction risk of opioids - Dosing: Always at the lowest effective dose to minimize side effects **Step 2: Mild-to-Moderate Pain (Intensity 4–6/10)** — **Weak Opioids ± Non-Opioids ± Adjuvants** - Weak opioids ("Step 2 opioids"): Codeine, tramadol, hydrocodone - Mechanism: Added to non-opioids (acetaminophen or NSAIDs) for synergistic effect - Principle: Combine weak opioids with non-opioids at the maximum recommended non-opioid dose - Adjuvants: Continue adjuvant medications if patient has neuropathic pain - Nursing note: Tramadol is increasingly used in the Philippines as it has both opioid and non-opioid analgesic effects **Step 3: Moderate-to-Severe Pain (Intensity 7–10/10)** — **Strong Opioids ± Non-Opioids ± Adjuvants** - Strong opioids: Morphine, hydromorphone, oxycodone, fentanyl, methadone - Principle: Use for cancer pain, severe acute pain, and palliative care; escalate doses as needed without arbitrary ceiling - Dosing: Titrate to effect in response to pain; there is no maximum dose for strong opioids when used appropriately for severe pain - Continue non-opioids and adjuvants as indicated - In the Philippines, morphine availability varies by region and facility; some patients may access opioids through pain specialists or academic medical centers **Key WHO Ladder Principles:** 1. **Pain assessment guides ladder placement** — Accurate pain rating determines which step to start at 2. **Around-the-clock dosing for continuous pain** — Do not give analgesics "as needed" for chronic or continuous pain; this leads to inadequate pain control and swinging pain levels. Schedule medications around the clock and add breakthrough medications for acute exacerbations 3. **Individualization** — Doses, routes, and intervals are adjusted based on patient response, age, renal/hepatic function, and comorbidities 4. **Route optimization** — Oral route is preferred when tolerated (convenient, patient autonomy); use IV for acute severe pain (faster onset); use alternative routes (transdermal, rectal, subcutaneous) when oral route is not feasible 5. **Multimodal approach** — Combine analgesics with different mechanisms to achieve better pain control at lower doses of each agent, reducing side effects 6. **Regular reassessment** — Evaluate pain control regularly and adjust medications accordingly 7. **Adherence to the ladder** — Progress sequentially through steps rather than jumping directly to strong opioids or using ineffectively low doses **Adjuvant Medications for Neuropathic Pain and Other Indications** — These are essential in Philippine pain management due to the high prevalence of neuropathic pain from diabetes: - **Anticonvulsants**: Gabapentin (Neurontin) and pregabalin (Lyrica) are particularly effective for neuropathic pain, neuropathic cancer pain, and postherpetic neuralgia. They reduce nerve excitability and are often first-line adjuvants in the Philippines - **Antidepressants**: Amitriptyline, nortriptyline, duloxetine, and venlafaxine provide analgesia for neuropathic pain and chronic pain with depression; work by increasing norepinephrine and serotonin - **Topical agents**: Lidocaine patches and capsaicin cream for localized neuropathic pain - **Corticosteroids**: Short-term use for inflammatory pain, cancer pain with swelling, and nerve compression pain - **Muscle relaxants**: For pain associated with muscle spasm - **Bisphosphonates and other bone-acting agents**: For bone metastasis pain **When to Use the WHO Ladder in Philippine Clinical Practice:** - Cancer pain (very common indication) - Chronic pain conditions (arthritis, chronic back pain, diabetic neuropathy) - Palliative and end-of-life care - Burn pain management - Trauma and postoperative pain management - Acute exacerbations of chronic illness The WHO ladder represents best practice pain management and is the standard taught in Filipino nursing schools and expected on the NLE. Mastery of this framework is essential for comprehensive patient care across all healthcare settings in the Philippines.

Non-opioid analgesics are foundational to pain management across the WHO ladder. Understanding their mechanisms, proper dosing, and serious adverse effects is critical for safe nursing practice in Philippine healthcare settings. **Acetaminophen (Paracetamol)** — The most commonly used over-the-counter analgesic in the Philippines **Mechanism of Action:** - Exact mechanism not fully understood; believed to work centrally in the brain (possibly through serotonergic and noradrenergic pathways) rather than peripherally like NSAIDs - Provides analgesia and antipyresis (fever reduction) - Has minimal anti-inflammatory effect **Dosing:** - Typical adult dose: 325–650 mg orally every 4–6 hours as needed, or 1000 mg (1 g) three to four times daily - Maximum daily dose in adults: Approximately 4 grams (4000 mg) per day; HOWEVER, some guidelines recommend lower limits (3000–3500 mg/day) in older adults, those with liver disease, chronic alcohol use, malnutrition, or renal impairment - Pediatric dosing: Weight-based, typically 10–15 mg/kg per dose **Advantages:** - Effective for mild to moderate pain - Well-tolerated with few side effects at appropriate doses - Available over-the-counter and inexpensive (important in resource-limited Philippine settings) - Safe in pregnancy (especially in third trimester); often chosen for obstetric pain management - Does not affect platelet function - Minimal GI effects compared to NSAIDs **CRITICAL NURSING CONSIDERATION — Hepatotoxicity:** The **most dangerous adverse effect of acetaminophen is hepatotoxicity (liver damage)**. This is a high-yield NLE topic. - **Mechanism**: Acetaminophen is metabolized in the liver; at therapeutic doses, it binds to glutathione and is safely excreted. However, at high doses or in susceptible patients, the glutathione supply is depleted, and toxic metabolites accumulate, causing hepatocellular necrosis - **Risk factors for hepatotoxicity**: - Doses exceeding the daily maximum - Chronic alcohol consumption (decreases hepatic glutathione stores) - Liver disease or cirrhosis - Malnutrition - Chronic illness - Concurrent use of other hepatotoxic drugs - **Signs and symptoms**: Right upper quadrant pain, jaundice, dark urine, pale stools, nausea, vomiting, fatigue - **Antidote**: **N-acetylcysteine (acetylcysteine or NAC)** — must be given promptly (ideally within 8 hours of overdose) to replenish hepatic glutathione stores **Nursing Responsibilities for Acetaminophen:** - Teach patients not to exceed 4 g/day (less if older, liver disease, or chronic alcohol use) - Counsel patients that many combination OTC medications (cold medicines, allergy medications) contain acetaminophen—check labels to avoid unintentional overdose - Monitor for signs of hepatotoxicity - If toxicity is suspected, report to provider immediately; acetylcysteine antidote is available **NSAIDs (Nonsteroidal Anti-Inflammatory Drugs)** — Inhibit prostaglandin synthesis and provide analgesia, anti-inflammation, and antipyresis **Common NSAIDs in Philippine Clinical Practice:** - Ibuprofen (Advil, Motrin): 200–400 mg every 4–6 hours; max 3200 mg/day - Naproxen (Naprosyn): 250–500 mg twice daily; max 1500 mg/day (500 mg naproxen base = 550 mg naproxen sodium) - Indomethacin (Indocin): 25–50 mg two to three times daily; often used for specific conditions - Meloxicam (Mobic): 7.5–15 mg once daily - **Ketorolac (Toradol): 30 mg IV/IM or 10 mg orally** — a potent NSAID reserved for SHORT-TERM acute pain management only (maximum 5 days) due to serious GI and renal risks with prolonged use - Aspirin: Primarily for cardiovascular protection rather than pain management in modern practice, though still used for mild analgesia **Mechanism of Action:** - Inhibit cyclooxygenase (COX) enzymes, which produce prostaglandins - Prostaglandins mediate pain, inflammation, and fever; reducing them decreases all three - Non-selective NSAIDs inhibit both COX-1 (responsible for protective gastric mucosa and platelet aggregation) and COX-2 (responsible for inflammation); this explains both their efficacy and their GI side effects - Selective COX-2 inhibitors (celecoxib) have less GI toxicity but similar cardiovascular risk **Advantages:** - Excellent for mild to moderate pain, especially inflammatory pain - No respiratory depression (safer than opioids) - No addiction potential - Antipyretic and anti-inflammatory properties - Available OTC and generally inexpensive - Can be used long-term in some conditions **SERIOUS ADVERSE EFFECTS — Nursing must monitor closely:** 1. **Gastrointestinal (GI) Bleeding and Ulceration** — The most common serious NSAID adverse effect - Mechanism: NSAIDs inhibit protective prostaglandins in gastric mucosa, reducing mucus and bicarbonate secretion, and increase gastric acid; they also inhibit platelet aggregation - Signs and symptoms: Black tarry stools (melena), bright red blood in vomit or stool, abdominal pain, hematemesis - Risk factors: Age over 60, history of peptic ulcer disease, concurrent use of corticosteroids or anticoagulants, H. pylori infection - Prevention: Give NSAIDs **with food** to minimize gastric irritation; consider concurrent proton pump inhibitor (PPI) or histamine-2 receptor antagonist (H2RA) in high-risk patients - Nursing action: Teach patients the warning signs; assess stools for blood; monitor hemoglobin if chronic use 2. **Renal Impairment** — Significant in the Philippine context where chronic kidney disease prevalence is increasing - Mechanism: Prostaglandins maintain renal blood flow; NSAIDs reduce renal perfusion - Risk factors: Older age, preexisting renal disease, dehydration, diabetes, concurrent ACE inhibitors or ARBs, concurrent diuretics - Prevention: Ensure adequate hydration; monitor renal function (BUN, creatinine, eGFR); use lowest effective dose for shortest duration - Nursing action: Assess fluid intake and output; monitor for signs of acute kidney injury; educate about avoiding NSAIDs with dehydration 3. **Increased Bleeding** — NSAIDs inhibit platelet aggregation - Risk factors: Concurrent anticoagulant or antiplatelet therapy, bleeding disorders, upcoming surgery - Prevention: Avoid in patients on warfarin or novel anticoagulants if possible; discontinue 3–7 days before surgery - Nursing action: Monitor for unusual bruising, bleeding gums, or nosebleeds 4. **Cardiovascular Effects** — NSAIDs increase cardiovascular events - Mechanism: Reduce protective prostacyclin while allowing prothrombotic thromboxane to persist; may increase blood pressure - Risk: Use cautiously in patients with hypertension, coronary artery disease, or heart failure - Nursing action: Monitor blood pressure; discourage long-term NSAID use in cardiovascular disease 5. **Allergic Reactions** — Particularly in patients with aspirin sensitivity - Cross-reactivity possible among NSAIDs - Some patients with asthma may experience bronchospasm **Special NSAID Considerations:** - **Ketorolac (Toradol)** is a potent NSAID used IV or IM for acute moderate-to-severe pain; highly effective but **must be limited to 5 days maximum** due to cumulative GI and renal toxicity risk; commonly used postoperatively in Philippine hospitals - **Indomethacin** is particularly useful for certain pain types (e.g., postdural puncture headache) but has more GI risk; used short-term - **Selective COX-2 inhibitors** (e.g., celecoxib) are somewhat safer for GI bleeding but carry similar or greater cardiovascular risk **Nursing Responsibilities for NSAIDs:** - **Always administer with food or milk** to reduce gastric irritation - Assess for GI risk factors; educate patients about symptoms of GI bleeding - Monitor renal function in chronic users - Ask about concurrent anticoagulant or antiplatelet use - Advise patients not to exceed recommended daily doses - Keep NSAIDs for the shortest duration possible - In the Philippines, educate patients that many OTC pain relievers are NSAIDs; help them understand the risks with long-term use - For ketorolac: confirm the dose (30 mg IV/IM or 10 mg orally), ensure duration limit, assess renal function and GI risk **Acetaminophen vs. NSAIDs: Quick Comparison for NLE:** - Both are first-line non-opioid analgesics - Acetaminophen: No GI or renal risk, but hepatotoxicity risk with overdose; no anti-inflammatory effect - NSAIDs: Anti-inflammatory, excellent for inflammatory pain, but GI bleeding, renal, and cardiovascular risks with chronic use - Choice depends on patient factors: use acetaminophen in patients with GI/renal disease; use NSAIDs in inflammatory conditions if no contraindications - Often used together in multimodal analgesia, but ensure total daily dose limits are not exceeded

Opioid analgesics are essential for moderate-to-severe pain management (Steps 2 and 3 of the WHO ladder) and are frequently tested on the NLE. Opioids bind to opioid receptors throughout the nervous system to provide potent analgesia. However, opioids carry serious risks, particularly respiratory depression, and nurses must understand safe administration, monitoring, and reversal with naloxone. The overarching principle is: **opioids provide crucial pain relief for patients in severe pain, and undertreating pain is harmful, but opioids must be used carefully with appropriate monitoring and safety measures.** **Common Opioid Analgesics Used in Philippine Healthcare:** **Morphine** — The reference opioid; WHO gold standard for strong opioid analgesia - IV dose: 2–10 mg IV push every 3–4 hours for acute pain (typical adult); titrate to effect - Oral dose: 10–30 mg orally every 3–4 hours (immediate-release) or 30–60 mg extended-release every 12 hours (chronic pain) - Duration: 3–4 hours (IV), up to 6 hours (oral) - Metabolism: Hepatic; renally excreted; caution in renal failure (active metabolites accumulate) **Fentanyl** — Synthetic opioid, 50–100 times more potent than morphine - IV dose: 25–100 mcg IV every 2–3 hours for acute severe pain; use for opioid-tolerant patients or titrate cautiously - Transdermal patch: 12–100 mcg/hour every 72 hours for chronic pain in opioid-tolerant patients (NOT for opioid-naive or acute pain) - Duration: 1–2 hours (IV), up to 72 hours (patch) - Advantage: Shorter duration may be preferable in rapid-titration situations (e.g., operating room) **Hydromorphone (Dilaudid)** — Synthetic opioid, approximately 5–7 times more potent than morphine - IV dose: 0.5–2 mg IV every 3–4 hours - Oral dose: 2–4 mg orally every 3–6 hours - Duration: 3–4 hours - May be preferred in renal impairment (metabolite less active) **Oxycodone** — Synthetic opioid, slightly more potent than morphine - Oral dose: 5–15 mg orally every 3–6 hours (immediate-release) or 10–80 mg extended-release every 12 hours (chronic pain) - Often combined with acetaminophen in products like Percocet - Cannot give IV (formulated for oral use) **Codeine** — Weak opioid, approximately 1/10 the potency of morphine; Step 2 opioid - Oral dose: 15–60 mg orally every 4–6 hours; max 240–360 mg/day - Some patients are poor metabolizers genetically and do not convert codeine to its active form; others are ultra-metabolizers and are at risk for toxicity - Often combined with acetaminophen in products available in Philippine pharmacies **Tramadol (Ultram)** — Weak synthetic opioid with dual action (opioid receptors + norepinephrine-serotonin reuptake inhibition) - Oral dose: 50–100 mg orally every 4–6 hours; max 400 mg/day (or 300 mg in older adults) - IV dose: 50 mg IV every 4–6 hours - Increasingly used in the Philippines; different mechanism makes it useful as bridge between non-opioids and strong opioids - Risk of serotonin syndrome when combined with SSRIs/SNRIs - Lower respiratory depression risk than other opioids but still requires monitoring **Methadone** — Long-acting synthetic opioid used primarily in opioid maintenance therapy and chronic severe pain - Complex pharmacology with variable half-life (24–72+ hours) - Requires careful dose titration to avoid toxicity - Used in specialized settings in the Philippines **Mechanisms of Action and Effects of Opioids:** Opioids bind to mu (μ), delta (δ), and kappa (κ) opioid receptors in the brain, spinal cord, and periphery. Mu-receptor activation is primarily responsible for: - **Analgesia** — decreased pain perception - **Euphoria** — the rewarding effect that can lead to psychological dependence - **Respiratory depression** — the most dangerous adverse effect - **Sedation and drowsiness** - **Constipation** — powerful effect mediated by mu receptors in the gut - **Nausea and vomiting** — via chemoreceptor trigger zone stimulation - **Urinary retention** — via mu receptors in the bladder - **Hypotension** — via vasodilation - **Miosis** (pinpoint pupils) — characteristic finding in opioid use/overdose - **Pruritus** — itching, possibly from histamine release **CRITICAL: Respiratory Depression** — The most serious adverse effect **Pathophysiology:** - Opioids suppress the respiratory center in the medulla, reducing the sensitivity to carbon dioxide - Results in decreased respiratory rate (bradypnea), decreased tidal volume, and irregular breathing patterns - Can progress to severe hypoxemia and hypercarbia (elevated CO2), leading to respiratory arrest and death **Risk Factors for Respiratory Depression:** - **Higher opioid doses** — dose-dependent effect - **Rapid IV administration** — delivers drug quickly to brain - **Opioid-naive patients** — those not accustomed to opioids have no tolerance - **Older age** — increased sensitivity, slower metabolism - **Concurrent CNS depressants** — alcohol, benzodiazepines, other sedatives potentiate respiratory depression - **Sleep apnea or other respiratory disease** — compromised baseline respiratory function - **Hepatic or renal impairment** — impaired drug metabolism/clearance - **Obesity** — increased risk of airway obstruction **Recognition of Respiratory Depression:** - **Early signs**: Increased sedation (drowsiness), difficulty staying awake, slurred speech, confusion - **Progressive signs**: Respiratory rate falling below 12 breaths per minute (common threshold), shallow breathing, use of accessory muscles - **Critical signs**: Respiratory rate below 8–10 bpm, profound sedation, decreased oxygen saturation (SpO2 <90%), cyanosis, unresponsiveness **Nursing Safety Rule for Opioids — CRITICAL NLE CONTENT:** **"Always assess the respiratory rate before administering an opioid. If the respiratory rate is below 12 breaths per minute (or per institutional protocol), HOLD the dose and notify the provider immediately."** This is one of the most frequently tested nursing safety concepts on the NLE. **Nursing Monitoring During Opioid Administration:** - Obtain baseline respiratory rate, oxygen saturation, blood pressure, level of consciousness, and pain rating - **Assess respiratory rate at regular intervals** (frequency depends on route and institutional protocol—typically every 2–4 hours for hospitalized patients on opioids, more frequently after IV doses) - Monitor for increasing sedation, which **precedes respiratory depression** - Maintain oxygen saturation monitor (pulse oximetry) if available - Monitor blood pressure for hypotension - Assess pupils (opioid effect causes miosis, pinpoint pupils) - Position patient to keep airway patent - Have **resuscitation equipment and naloxone readily available** **Other Opioid Adverse Effects and Management:** **Constipation** — Occurs in 40–100% of opioid users; tolerance does not develop - Mechanism: Opioids increase fluid absorption in the colon and reduce peristalsis - Prevention: **Proactive bowel regimen is essential** — do not wait for constipation to develop - Increase fluid intake (8–10 glasses/day) - Increase dietary fiber (fruits, vegetables, whole grains) if tolerated - Increase physical activity as tolerated - Initiate **stimulant laxative** (e.g., bisacodyl, senna) at the same time opioid therapy begins - Consider stool softener (docusate) if patient has hard stools - In severe cases or when oral measures inadequate, use osmotic laxatives (polyethylene glycol, lactulose) or naloxegol (peripheral opioid antagonist that reverses opioid-induced constipation without affecting analgesia) - Assessment: Ask about bowel habits; assess abdominal distension, pain, or hardness (impaction) **Nausea and Vomiting** — Occurs in 20–40% of patients, especially with initial doses - Mechanism: Opioids stimulate chemoreceptor trigger zone - Prevention: Premedicate with antiemetic (ondansetron, metoclopramide, prochlorperazine) before opioid administration - Management: Most tolerance develops within 1–2 weeks; switch antiemetics if needed - Assessment: Ask about nausea; assess for vomiting episodes, intake, and nutritional status **Sedation and Drowsiness** — Expected initial effect, usually improves with tolerance - Safety concern: Patient must not operate machinery or drive - Tolerance typically develops within days to weeks - If persistent and problematic, discuss with provider for dose adjustment or addition of stimulant (e.g., methylphenidate) or agent change - **CRITICAL**: Monitor sedation level carefully; **increasing drowsiness warns of impending respiratory depression** **Urinary Retention** — Opioids increase bladder smooth muscle tone - Affects 10–30% of patients, particularly postoperative patients - Risk factors: Pelvic/abdominal surgery, spinal anesthesia, higher opioid doses - Assessment: Assess for difficulty urinating, bladder distension, discomfort - Prevention: Ensure privacy, position upright if tolerated, ensure adequate fluid intake, monitor intake and output - Management: Catheterization may be necessary if retention is significant **Hypotension** — From opioid-induced vasodilation - Risk: Older adults, hypovolemia, concurrent vasodilators - Assessment: Monitor blood pressure regularly; assess for dizziness or syncope - Management: Ensure adequate fluid intake; assist with position changes; avoid rapid position changes **Pruritus (Itching)** — From histamine release or central mechanism - Management: If bothersome, antihistamines (diphenhydramine) or naloxone (paradoxically, low-dose naloxone may relieve itch without reversing analgesia) **Important Distinctions: Tolerance, Physical Dependence, and Addiction** — The NLE frequently tests understanding of these distinct concepts **Tolerance:** - Definition: The body's decreasing response to a drug with repeated use; the same dose provides less effect over time - Mechanism: Downregulation of opioid receptors, increased metabolism - Occurs: With all regular opioid use - Implication: Requires **dose escalation** to maintain pain relief; dose escalation is appropriate and necessary, NOT a sign of addiction - Is **reversible** — tolerance decreases if the drug is discontinued and the patient allowed a washout period **Physical Dependence:** - Definition: An involuntary physiologic state in which the body adapts to the drug; abrupt discontinuation causes withdrawal symptoms - Signs of withdrawal: Anxiety, irritability, insomnia, sweating, muscle aches, GI distress, dilated pupils (opposite of opioid effect) - Occurs: With regular opioid use, even at prescribed therapeutic doses - Implication: Opioids should be **tapered gradually** rather than stopped abruptly; physical dependence is not addiction - Is **reversible** — can be managed with slow tapering - Occurs in almost all patients on chronic opioids; **not a sign of addiction** **Addiction (Opioid Use Disorder):** - Definition: A psychological and behavioral condition characterized by compulsive drug-seeking and use despite awareness of harm; is a loss of control - Hallmarks: Drug-seeking behaviors, using more than prescribed, using for non-pain relief (euphoria-seeking), continued use despite adverse consequences, social/occupational impairment - Occurs: In some individuals, not all; may have genetic/biological predisposition - Is **NOT equivalent to tolerance or dependence** - Implication: Patients with pain deserve adequate opioid therapy; having pain and requiring opioid dose escalation does NOT indicate addiction; addiction is characterized by loss of control and drug-seeking behavior, not by dose escalation for legitimate pain relief **Nursing Perspective on Addiction:** - **Do NOT undertreat pain out of fear of "making the patient an addict."** This is a serious nursing error - A patient who requires escalating opioid doses for escalating pain is exhibiting tolerance, not addiction - A patient with a history of substance use disorder still deserves adequate pain relief - If managing pain in a patient with known opioid use disorder, coordinate with addiction specialists, maintain clear boundaries, use contracts if necessary, but do not deny appropriate analgesia - Opioid-induced physical dependence is an expected and reversible physiologic effect, not a reason to withhold pain medication **NALOXONE: OPIOID REVERSAL AGENT** — Critical for NLE and clinical practice **What is Naloxone?** - A competitive opioid antagonist that binds to mu opioid receptors with higher affinity than opioids, displacing opioid molecules - Causes rapid reversal of opioid effects, especially respiratory depression - Brand name: Narcan **When to Give Naloxone:** - **Suspected opioid overdose with respiratory depression** — respiratory rate severely depressed, decreased level of consciousness, pinpoint pupils, decreased oxygen saturation - Not given for mild-moderate respiratory depression (respiratory rate 12–14 bpm) — instead, reduce opioid dose or hold next dose **Dosing:** - **IV dose: 0.4–2 mg IV push** (typical starting dose 0.4 mg); may repeat every 2–3 minutes up to 10 mg total if no response - **IM/SC dose: 0.4–2 mg** if IV access not available; takes longer to work (2–3 minutes) compared to IV (30–60 seconds) - **Intranasal formulation (Narcan nasal spray)**: 4 mg per spray; emerging option for emergency/public use **Mechanism of Reversal:** - Naloxone displaces opioids from receptors, immediately reversing respiratory depression, sedation, and analgesia - Patient often becomes alert; respiratory rate increases; oxygen saturation improves - Effect is relatively short-lived: **30–90 minutes** (much shorter than most opioids), meaning **the opioid effect may return after naloxone wears off, and the patient may have renewed respiratory depression** - Therefore, **naloxone may need to be repeated** or given as an **IV infusion** if the opioid overdose is severe or the opioid is long-acting **Critical Side Effects of Naloxone:** - **Acute withdrawal syndrome** — Patient may experience sudden, severe withdrawal symptoms: - Agitation, anxiety, tremor, sweating, tachycardia, hypertension - Muscle and bone pain - Severe headache - This is acutely uncomfortable but not life-threatening; explain to patient that it is temporary and necessary to reverse the overdose - **Return of severe pain** — Because opioid analgesia is reversed, the patient's pain returns acutely; be prepared to re-administer pain medication once respiratory status is stabilized - **Pulmonary edema** — Rare but serious complication associated with opioid overdose; manage with oxygen, upright positioning, and supportive care **After Naloxone Administration:** - Monitor the patient closely; respiratory depression may recur as naloxone wears off - Maintain IV access; have resuscitation equipment ready - Monitor vital signs frequently - Do not assume the crisis is over; provide ongoing support - **Observe for at least 2–3 hours** after naloxone administration - If a naloxone IV infusion is running, do not suddenly discontinue it; taper it - If the overdose involved a long-acting opioid (e.g., methadone, extended-release morphine), extended monitoring and possibly extended naloxone therapy may be needed - Report the event to the provider; collaborate on preventing future overdoses **Availability of Naloxone in Philippine Healthcare:** Naloxone availability varies by facility. Nurses should: - Know where naloxone is stored in their unit (crash cart, pharmacy, ICU) - Understand the institutional protocol for naloxone administration - Ensure naloxone is immediately accessible on units where opioids are regularly given - Advocate for naloxone availability, especially in units caring for patients with opioid use disorders or severe pain - Educate patients and families about naloxone if the patient is at high overdose risk **Patient and Family Education on Opioids:** - Explain the expected effects and side effects - Emphasize not to operate machinery or drive while taking opioids - Warn against alcohol or other CNS depressants with opioids (serious respiratory depression risk) - Explain the need for a bowel regimen - Discuss the difference between tolerance, dependence, and addiction to reduce stigma and shame - Advise on safe storage (locked container, away from children and adolescents) - Educate on proper disposal of unused opioids (do not flush unless instructed; many communities have drug disposal programs) - Teach that it is important to take pain medication BEFORE pain becomes severe rather than waiting until pain is 10/10

Patient-controlled analgesia (PCA) is a medication delivery system that empowers patients to self-administer a preset dose of opioid when they press a button, improving pain control and patient satisfaction. PCA is commonly used in postoperative settings, cancer pain management, and acute pain situations in Philippine hospitals. Understanding PCA mechanism, safety features, and nursing responsibilities is essential for NLE preparation and clinical safety. **Mechanism of PCA:** **Basic Operation:** - An IV infusion pump is programmed with specific medications, doses, and timing parameters - The patient wears or holds a button (patient control button) connected to the pump - When the patient perceives pain returning, they press the button - The pump delivers one **bolus dose** (a set amount of medication, typically 1–5 mg of morphine or equivalent) into the IV line - The medication takes effect within 5–15 minutes (faster than IM injection, slower than IV push; represents IV infusion through the IV line) - Pain relief follows as the medication circulates - The patient can press the button again when pain returns **Advantages Over Traditional "As Needed" (PRN) Dosing:** - **Improved pain control**: Patient does not have to wait for nurse to respond to call bell, prepare medication, and administer; pain relief can begin as soon as patient perceives need, before pain escalates to 9–10/10 - **Psychological benefit**: Patient has sense of control; reduces anxiety and helplessness - **Better blood levels**: Because patient self-administers small doses frequently, opioid serum levels remain more stable, preventing the "swinging" levels (excessive pain at 3 hours post-dose, oversedation at 30 minutes post-dose) seen with traditional dosing - **Reduced total opioid use**: Paradoxically, patients on PCA often use less total medication than patients on PRN dosing because they maintain steady pain control rather than playing "catch-up" with severe pain - **Improved patient satisfaction**: Improved pain control and sense of control enhance satisfaction scores **PCA Safety Features:** **1. Lockout Interval (Lockout Period)** - Definition: The minimum time that must elapse between bolus doses - Duration: Typically 6–10 minutes (varies by institutional protocol and drug choice) - Function: **Prevents accidental overdose** by limiting how frequently doses can be delivered - How it works: Even if the patient presses the button 30 seconds after the last dose, no medication will be delivered until the lockout period expires (e.g., 10 minutes after the previous dose) - Nursing relevance: Educate the patient that a waiting period exists; pressing the button repeatedly will not deliver repeated doses **2. Maximum Dose Limits (4-Hour Lock)** - Definition: The maximum cumulative amount of medication that can be delivered within a specified time window (typically 4 hours) - Function: **Additional overdose protection** if the patient repeatedly presses the button during the lockout period - How it works: Once the maximum 4-hour dose is reached, the pump will not deliver additional medication until the 4-hour window "rolls over" - Nursing relevance: Understand institutional dose limits; monitor total medication delivered **3. Concentration and Pump Programming Safeguards** - Medications and concentrations are standardized (e.g., morphine 1 mg/mL dilution) - Two nurses typically verify the medication, concentration, dose, bolus amount, lockout interval, and 4-hour maximum before initiating PCA (similar to double-check for blood administration) - This verification prevents medication errors **Indications for PCA in Philippine Clinical Settings:** - Postoperative pain management (very common use) - Cancer pain management - Acute trauma pain - Sickle cell pain crisis - Burn pain - Myocardial infarction pain - Terminal/palliative care **CRITICAL SAFETY PRINCIPLE: "PCA by Proxy" is Absolutely Prohibited** This is a high-yield NLE safety concept. **Only the patient should press the PCA button. Family members, visitors, and even nurses or other staff members must NOT press the button for the patient.** This practice, known as "PCA by proxy," is dangerous because: - **Overdose risk**: The surrogate (family member, staff) may not understand the patient's pain needs and may press the button excessively, delivering more medication than the patient would have requested - **Loss of patient control and feedback**: The patient may not be aware that a dose was delivered and therefore not request doses appropriately - **Potential for harm to unconscious/sedated patients**: An unconscious or heavily sedated patient cannot report oversedation, respiratory depression, or other adverse effects - **Legal and ethical issues**: Administering medication at the request of someone other than the patient violates informed consent and patient autonomy **Nursing Responsibility:** Educate the patient and family that ONLY the PATIENT presses the button. If a patient is too sedated or unable to press the button independently, PCA may not be appropriate; discuss with the provider. **Medications Commonly Used in PCA:** - **Morphine**: Most common; typical bolus dose 1–3 mg, lockout 6–10 minutes - **Fentanyl**: For opioid-tolerant patients; typical bolus 10–25 mcg, lockout 6–10 minutes - **Hydromorphone**: Bolus dose 0.2–0.5 mg, lockout 6–10 minutes (used when morphine not tolerated or for renal impairment) - **Meperidine (Demerol)**: Less commonly used now due to neurotoxic metabolites and risk of serotonin syndrome; if used, lower doses, shorter duration **Nurse Responsibilities in PCA Management:** **Before PCA Initiation:** 1. **Verify the order** — Confirm medication, dose, bolus amount, lockout interval, and 4-hour maximum with provider order 2. **Two-nurse verification** — With a second nurse (following institutional protocol), verify: - Medication name and concentration - Ordered bolus dose (e.g., 1 mg morphine) - Ordered lockout interval (e.g., 10 minutes) - Ordered 4-hour maximum (e.g., 30 mg) - Patient name and medical record number - Expiration dates on medication vials 3. **Assess baseline pain and vital signs** — Obtain baseline respiratory rate (CRITICAL), oxygen saturation, blood pressure, heart rate, level of consciousness, and pain rating 4. **Assess for contraindications** — Respiratory disease, opioid allergy, altered mental status that might prevent safe button-pressing 5. **Patient and family education**: - Explain what PCA is and how it works - Teach the patient to press the button when pain begins (not waiting until pain is severe) - Emphasize that ONLY the PATIENT presses the button — explain the danger of PCA by proxy - Explain the lockout period and that pressing repeatedly will not speed up medication delivery - Teach expected effects (pain relief) and side effects (drowsiness, constipation) - Answer questions; reduce anxiety **During PCA Use:** 1. **Respiratory monitoring** — This is the highest priority: - Monitor and document respiratory rate at least every 2–4 hours (or per institutional protocol) - Assess for increasing sedation, which precedes respiratory depression - Assess oxygen saturation; use continuous pulse oximetry if available - If respiratory rate falls below 12 bpm or oxygen saturation drops below 90%, notify provider immediately; consider supplemental oxygen 2. **Pain assessment** — - Regularly assess pain control (e.g., every 2–4 hours) - Ask if the patient is satisfied with pain relief - If pain relief is inadequate, communicate with provider (may need bolus dose increase, more frequent bolus availability, or basal infusion) 3. **Monitor PCA pump function**: - Check that pump is running and IV site is patent - Verify that medication is infusing and IV catheter is secure - Assess IV site for redness, swelling, or leakage; change IV site if signs of infiltration - Monitor total doses delivered and attempts (discrepancy between attempts and delivered doses indicates lockout function is working; if all attempts are delivered, patient may need dose adjustment) 4. **Assess other vital signs and effects**: - Blood pressure and heart rate - Gastrointestinal tolerance (nausea, vomiting, constipation) - Level of consciousness and alertness - Identify adverse effects and manage (e.g., antiemetic for nausea, laxative for constipation) 5. **Safety verification**: - Ensure naloxone and resuscitation equipment are immediately available - Confirm family members understand PCA by proxy prohibition - Check pump security (pump in locked bedside stand if available, securing against theft or tamper) 6. **Documentation**: - Record pain ratings before and after PCA use - Document doses delivered and total dose over 24 hours - Note attempts vs. delivered doses (indicates patient engagement and pump function) - Document respiratory rate, oxygen saturation, and adverse effects - Note patient education provided **After PCA Discontinuation:** 1. Transition to next pain management plan (e.g., PO opioids, non-opioids, other modalities) 2. Assess comfort during transition; patients on higher PCA doses need higher-dose oral medications to prevent breakthrough pain 3. Remove IV catheter if no longer needed 4. Document final PCA dose totals 5. Continue assessment for pain and adverse effects with new regimen **Advantages and Limitations of PCA in Philippine Context:** **Advantages:** - Excellent pain control for postoperative and acute pain in settings with IV access - Improves patient satisfaction and reduces anxiety - Often reduces total opioid use compared to PRN dosing - Suitable for patients who can independently press a button **Limitations:** - Requires IV access; not suitable for patients without IV lines or in outpatient primary care settings - Requires patient cooperation and understanding; not suitable for unconscious or severely confused patients or very young children - Requires monitoring and pump maintenance - More expensive than PRN dosing (pump cost, setup time) - In resource-limited settings in the Philippines, IV opioid availability and nursing time for monitoring may be limited; not all facilities have PCA capabilities **Troubleshooting Common PCA Issues:** | Issue | Possible Cause | Nursing Action | |-------|----------------|----------------| | Patient reports no pain relief despite frequent button pressing | Lockout interval limiting medication delivery; inadequate bolus dose | Verify lockout is appropriate; check total doses delivered; communicate with provider about dose adjustment | | IV site is swollen, red, or painful | IV infiltration or phlebitis | Stop infusion; remove IV catheter; establish new IV access; assess for extravasated opioid injury | | Pump displays error message | Pump malfunction; medication vial empty | Follow pump troubleshooting protocol; replace vial if empty; contact biomedical engineering if mechanical failure | | Patient is drowsy and respiratory rate is 10 bpm | Opioid-induced respiratory depression | HOLD PCA; notify provider; prepare naloxone; assess for other causes of drowsiness; may need to reduce dose | | Patient presses button frequently (e.g., 30+ attempts in 1 hour) | Inadequate pain control; patient anxiety about pain; patient confusion | Verify dose is appropriate; assess pain (may need provider to increase dose); reassure patient about lockout; educate if patient presses excessively thinking more button presses will speed up medication | | Family member presses button for patient | PCA by proxy | STOP immediately; educate family member; reinforce with patient that only patient should press button; if family member does not comply, consider removing button from family access or discontinuing PCA | **PCA in Special Populations:** **Older Adults:** - Use lower starting doses due to increased sensitivity - Expect increased sedation - More frequent monitoring of respiratory status - Assess cognition (if confused, PCA may not be appropriate) **Opioid-Tolerant Patients (Chronic Pain, Substance Use Disorder History):** - May require higher bolus doses - May require lower lockout interval to allow more frequent dosing - Clear communication about pain management goals - Coordinate with pain specialists or addiction medicine if applicable **Pediatric Patients:** - Very young children (under 6 years) may not understand button-pressing; PCA less suitable - School-age children (6–12 years) can use PCA with education and supervision - Adolescents typically use PCA effectively - Use lower bolus doses appropriate for weight and opioid tolerance - Enhanced monitoring due to developmental factors **End-of-Life and Palliative Care:** - PCA is excellent for comfort management in dying patients - Patients can self-titrate medication for pain and dyspnea - Less monitoring focus on preventing overdose; goal is comfort - Family education becomes more important

Non-pharmacologic pain management strategies are evidence-based interventions that complement medication and provide patients with active, safe alternatives for pain relief. These strategies are aligned with holistic nursing care principles, the gate control theory of pain, and WHO pain management guidelines. In the Philippine healthcare context, where medication access may be limited in some settings, non-pharmacologic strategies are particularly valuable and often culturally acceptable. The NLE expects nurses to understand the mechanism and application of these interventions. **Theoretical Basis: Gate Control Theory and Endogenous Pain Modulation** Non-pharmacologic strategies work primarily through the gate control mechanism discussed earlier: non-painful stimuli can "close the gate" at the spinal cord level, reducing pain transmission to the brain. Additionally, these strategies activate the body's endogenous pain-suppressing systems (endorphin release, parasympathetic activation) and reduce anxiety and tension, which amplify pain perception. **Categories of Non-Pharmacologic Interventions:** **1. Cutaneous (Physical) Stimulation** **Heat Application** - Mechanism: Increases blood flow to the area, reduces muscle tension, activates non-pain nerve fibers (closes the gate) - Applications: Heat packs, warm baths, warm compresses, heating pads - Effective for: Muscle tension, joint pain, arthritis, dysmenorrhea, some postoperative pain - Precautions: Not for acute inflammation in first 24–48 hours (risk of increased swelling); not for patients with diminished sensation (burns risk); avoid over bony prominences - Duration: 15–20 minutes, several times daily as needed - Filipino context: Warm compresses, warm water bottles, herbal warm oils are culturally familiar **Cold Application** - Mechanism: Numbs sensation, reduces inflammation, vasoconstricts (reduces swelling) - Applications: Ice packs, cold compresses, ice massage - Effective for: Acute injury (first 24–48 hours), acute inflammation, some types of acute pain, arthritis during flare-up - Precautions: Can increase muscle tension if applied too long; not for patients with cold intolerance or Raynaud's phenomenon - Duration: 10–15 minutes every 1–2 hours - Application method: Wrap in cloth (direct contact with ice can cause skin damage) **Massage and Pressure** - Mechanism: Activates non-pain nerve fibers, reduces muscle tension, increases circulation, promotes relaxation - Techniques: - **Gentle effleurage** (light stroking): Calming, promotes relaxation - **Petrissage** (kneading): Reduces muscle tension in deeper muscles - **Counterpressure**: Firm, sustained pressure applied during contractions (very effective for labor pain) - **Acupressure**: Applying sustained pressure to specific points (acupoints) - Effective for: Muscle pain, tension, labor pain, anxiety-related pain, postoperative pain - Filipino context: Massage (hilot) and acupressure are traditional healing practices in Filipino culture; very culturally acceptable - Caution: Avoid massage over areas of thrombophlebitis, wounds, or recent surgery **Transcutaneous Electrical Nerve Stimulation (TENS)** - Mechanism: Delivers mild electrical impulses through skin electrodes; stimulates non-pain nerve fibers, triggering gate control mechanism - Equipment: TENS unit with electrodes placed on skin near the pain site - Settings: Frequency (Hz) and intensity adjusted based on patient tolerance and pain type; typically 50–100 Hz for acute pain - Effective for: Chronic pain conditions, postoperative pain, musculoskeletal pain, labor pain - Advantages: Non-invasive, reusable equipment, patient can control intensity - Precautions: Not for patients with pacemakers (electrical interference); not over the carotid artery, anterior neck, or lower back in pregnant patients - Duration: 20–30 minutes, several times daily - Filipino context: TENS units are becoming increasingly available in Philippine hospitals and pain clinics **Vibration** - Mechanism: Similar to massage; activates non-pain receptors - Applications: Mechanical vibrators or hand vibration during contractions - Effective for: Labor pain, postoperative pain **2. Cognitive-Behavioral Interventions** **Relaxation Techniques** - Mechanism: Reduce muscle tension, activate parasympathetic nervous system, decrease anxiety (which amplifies pain), lower blood pressure and heart rate - Types: - **Progressive Muscle Relaxation**: Systematically tensing and releasing muscle groups from toes to head; takes 10–20 minutes - **Deep Breathing/Diaphragmatic Breathing**: Slow, deep breaths from the diaphragm (not shallow chest breathing); 5–10 minutes - **Autogenic Relaxation**: Repeating calming phrases (e.g., "my legs are heavy and warm") - Effective for: All pain types; particularly useful for anxiety-related pain exacerbation - Filipino context: Easy to teach; can be practiced anywhere; combines well with spiritual practices - How nurse facilitates: Teach the technique, guide the patient through it initially, practice before pain crisis, use during pain exacerbation **Guided Imagery and Visualization** - Mechanism: Focuses attention away from pain (distraction), activates endogenous pain suppression, reduces anxiety - Technique: Patient imagines a peaceful, pain-free scene in detail (engaging all senses) - Guide the patient through description of environment, sensations, sounds, scents - Encourage patient to "go to" this mental place when in pain - Duration: 10–20 minutes - Effective for: All types of pain; especially useful for anticipatory pain and anxiety - Examples of peaceful scenes: Beach, forest, childhood memory, spiritual/religious place - Filipino context: Can incorporate cultural and spiritual imagery that is personally meaningful to the patient - Note: Some patients may find guided imagery uncomfortable or triggering; offer choice of strategies **Distraction Techniques** - Mechanism: Diverts attention from pain; reduces pain perception when attention is focused elsewhere - Methods: - **Music**: Listening to preferred music (especially effective for acute pain and anxiety; 30–60 minutes) - **Television or movies**: Engaging visuals and audio - **Reading or audiobooks**: Intellectual engagement - **Games, puzzles, or crafts**: Active engagement - **Conversation and social interaction**: Connection reduces loneliness and amplifies pain perception - **Virtual reality**: Emerging technology for immersive distraction (available in some advanced pain centers) - Duration: As long as pain persists; some effects (especially music) last 1–2 hours post-listening - Effective for: Acute pain, breakthrough pain, anticipatory pain - Filipino context: Music is culturally important; social interaction and family presence are valued; video entertainment is increasingly available **Mindfulness and Meditation** - Mechanism: Non-judgmental awareness of the present moment; changes relationship with pain (accepting pain without fighting it) rather than eliminating pain; reduces anxiety and emotional suffering - Technique: Focusing attention on breath, body sensations, or a mantra; observing thoughts/sensations without judgment - Duration: 5–20 minutes daily for benefits; benefits increase with regular practice - Effective for: Chronic pain, anxiety, depression associated with pain - Note: Requires practice; less immediately effective than distraction but provides long-term coping skill **Biofeedback** - Mechanism: Patient receives feedback on physiologic processes (heart rate, muscle tension, skin temperature) and learns to consciously control them - Equipment: Biofeedback monitor connected to sensors on patient's body - Effective for: Chronic pain associated with muscle tension, headaches, fibromyalgia - Requires training and repeated sessions to develop skill - Less commonly available in Philippine clinical settings but valuable for chronic pain management **Cognitive Therapy** - Mechanism: Identifies and challenges pain-amplifying thoughts; replaces catastrophizing ("this pain will never go away") with realistic, helpful thoughts - Examples: - Pain thought: "This pain is unbearable and will never stop" - Reframed thought: "This pain is severe right now, but I have coped with this before and have pain relief strategies" - Effective for: Chronic pain, especially when depression/anxiety are prominent - Usually involves consultation with mental health professional **3. Physical and Positioning Interventions** **Positioning and Immobilization** - Mechanism: Reduces movement of injured area, prevents further tissue trauma, reduces muscle tension - Applications: - **Proper body alignment**: Pillow support for comfortable alignment - **Immobilization**: Sling, brace, or splint to prevent movement of injured extremity - **Elevation**: For acute injury (reduces swelling) - **Position changes**: Frequent position changes prevent stiffness and pressure ulcers - Effective for: Acute injury, postoperative pain, musculoskeletal pain - Filipino context: Family can assist with positioning; education on proper positioning is important **Rest and Sleep** - Mechanism: Pain is amplified by fatigue and sleep deprivation; adequate sleep allows nervous system recovery and pain-suppressing mechanism activation - Interventions: - Ensure adequate sleep (7–8 hours); pain disrupts sleep in a vicious cycle - Use comfort measures (quiet environment, comfortable temperature, familiar bedding) - Avoid caffeine/stimulants in evening - Coordinate pain medication with sleep schedules (give medication before bed so pain-free sleep is possible) - Effective for: All pain types, especially chronic pain - Assessment: Ask about sleep quality; insomnia is a sign that pain management is inadequate **Physical Therapy and Exercise** - Mechanism: Maintains mobility, prevents deconditioning, strengthens supporting muscles, improves mood and endorphin release - Types: - **Gentle range-of-motion exercises**: Prevent stiffness, maintain function - **Stretching**: Reduces muscle tension - **Strengthening exercises**: Builds muscle support - **Aerobic activity**: Walking, swimming, cycling (pain-relieving effects of exercise) - **Yoga**: Combines stretching, strengthening, relaxation - Effective for: Chronic pain, postoperative rehabilitation, musculoskeletal pain - Assessment: Work with physical therapist to develop appropriate exercise plan - Caution: Exercise should not increase pain significantly; communicate with therapist if pain worsens **4. Complementary and Alternative Therapies (Increasingly Integrated)** **Acupuncture and Acupressure** - Mechanism: Traditional Chinese medicine; stimulates specific points to balance energy (qi) and activate endogenous pain modulation - Acupuncture: Fine needles inserted at acupoints - Acupressure: Finger/hand pressure applied to same points (non-invasive alternative) - Evidence: Increasingly supported by research for certain pain conditions (arthritis, headaches, neuropathic pain) - Effective for: Chronic pain, neuropathic pain, headaches - Filipino context: Growing acceptance; some academic medical centers have acupuncture services - Note: Should be performed by trained practitioners; accreditation varies **Herbal Remedies and Supplements** - Examples: Turmeric (curcumin, anti-inflammatory), ginger (anti-inflammatory), cannabis/medical marijuana (where legal), topical herbal oils, St. John's Wort - Caution: Many herbs interact with medications; patients should inform healthcare providers of herbal use - Evidence: Varies; some have research support, others limited evidence - Filipino context: Traditional herbal use is common; nurses should inquire about herbal remedies and communicate with providers **Spiritual and Religious Practices** - Mechanism: Provides comfort, meaning, connection, and psychological/spiritual relief - Examples: Prayer, meditation, religious rituals, pastoral care, chaplain support, faith community visits - Effective for: All pain; especially comforting when pain is severe or end-of-life - Nursing role: Assess spiritual beliefs, facilitate spiritual practices, respect diverse beliefs, consult chaplain or spiritual advisor as appropriate - Filipino context: Majority Filipino population is religious (Catholic, Christian, Muslim); spiritual support is important and often integrated into family care **Environmental Modifications** - Mechanism: Reduces environmental stressors that amplify pain perception - Strategies: - **Quiet, peaceful environment**: Reduce noise, harsh lighting - **Temperature control**: Comfortable room temperature - **Lighting**: Soft, non-harsh lighting - **Privacy**: Respect for dignity - **Family presence**: Often comforting; cultural value in Filipino context - **Removal of unnecessary equipment**: Reduces clutter and anxiety - Effective for: All pain; especially important for anxiety and sleep **5. Combination Multimodal Approach** Most effective pain management combines multiple non-pharmacologic strategies plus medication: - Example for postoperative pain: Opioid medication + TENS + guided imagery + ambulation + family support - Example for chronic pain: Non-opioid analgesic + gabapentin + relaxation + exercise + acupuncture + spiritual support - Multimodal approach reduces opioid requirements, improves pain control, and enhances coping **Integration with Pharmacologic Management:** Non-pharmacologic strategies should **never replace medication for severe pain**, but they **enhance medication effectiveness**, allowing: - Lower opioid doses with better pain control - Reduced opioid side effects (lower doses cause less constipation, sedation) - Improved patient satisfaction - Enhanced patient agency and sense of control - Potentially shorter recovery in postoperative settings **Barriers to Non-Pharmacologic Interventions in Philippine Context:** - **Limited time and resources**: Nurses may lack time for lengthy interventions (guided imagery, massage) in understaffed settings - **Patient education gaps**: Patients may be unfamiliar with these interventions - **Cost**: Some interventions (TENS, acupuncture) may not be available or affordable - **Equipment availability**: TENS units, biofeedback equipment not universally available **Nursing Strategies to Overcome Barriers:** - **Teach simple, quick interventions** that patients can do independently (breathing, music, positioning) - **Involve family**: Family can provide massage, music, company, spiritual support - **Use available resources**: Music players, warm water, pillows - **Educate on free or low-cost interventions**: Deep breathing, relaxation, exercise - **Integrate into routine care**: Position changes, rest, immobilization done anyway; explain pain-relief mechanism - **Advocate for resources**: Work with health facility leadership to obtain TENS units, audiovisual equipment **Reassessment After Non-Pharmacologic Interventions:** As with medication, reassess pain 15–30 minutes after non-pharmacologic intervention to evaluate effectiveness. Document interventions used and patient response (e.g., "Applied warm compress × 20 minutes; pain improved from 7/10 to 4/10; patient reports decreased muscle tension"). This documents the value of nursing interventions in patient care.

Chronic pain (persistent pain lasting longer than 3–6 months) presents unique management challenges requiring a multimodal, interdisciplinary approach that differs fundamentally from acute pain management. Understanding chronic pain psychology, the role of functional goals, and the complex issues of tolerance, dependence, and addiction is critical for NLE success and for providing compassionate, evidence-based care to patients with chronic conditions common in the Philippines (arthritis, diabetes-related neuropathy, chronic back pain). **Characteristics of Chronic Pain Revisited:** - **Duration**: Persists beyond expected healing period (>3–6 months) - **Physiologic signs**: Often **absent** or **diminished** — the body adapts, so tachycardia, hypertension, diaphoresis that accompany acute pain may not be present; this can lead to underestimation of pain severity - **Psychological consequences**: High prevalence of depression (30–50% of chronic pain patients), anxiety, sleep disturbance, fatigue, hopelessness - **Functional limitations**: Significant impact on activities of daily living, work, social participation, relationships, sexual function, and quality of life - **Pain variability**: Pain intensity may fluctuate; some days better, some worse - **Multiple pain components**: Often combines nociceptive (from tissue damage) and neuropathic (from nerve damage) pain - **Psychosocial factors**: Stress, trauma, coping mechanisms, social support, beliefs about pain, and past experiences significantly influence pain severity and disability **Physiologic Differences: Central Sensitization** In chronic pain, the nervous system undergoes changes called **central sensitization**, where: - The spinal cord becomes "wind up" or hypersensitive - Lower-intensity stimuli cause pain (allodynia — pain from normally non-painful stimulus, like light touch causing pain) - Pain is amplified (hyperalgesia) - The descending pain inhibition system becomes less effective - This explains why chronic pain becomes worse and spread despite healing of original injury **The Biopsychosocial Model of Chronic Pain** Management requires addressing all three dimensions: **Biologic Factors:** - Pain mechanism (nociceptive vs. neuropathic) - Underlying disease (arthritis, neuropathy, cancer) - Medication effects and drug interactions - Sleep quality - Physical function and fitness **Psychological Factors:** - Pain-related beliefs ("I will never get better," "pain means tissue damage") — often catastrophizing - Depression and anxiety - Coping strategies (active vs. avoidant coping) - History of trauma or adverse experiences - Locus of control (sense of agency in managing pain) - Fear-avoidance (avoiding activities due to fear of pain, causing deconditioning) **Social Factors:** - Family dynamics and support - Work/occupational factors - Social relationships and isolation - Cultural beliefs about pain - Healthcare system access - Financial stress - Stigma and discrimination (especially if pain is invisible or if opioid use is involved) **Pharmacologic Management of Chronic Pain** **Foundational Principles:** 1. **WHO Analgesic Ladder**: Use step-by-step approach; progress from non-opioid through weak to strong opioids as needed 2. **Around-the-clock dosing**: For continuous chronic pain, administer long-acting analgesics on a scheduled basis rather than PRN - Example: Extended-release morphine 30 mg twice daily (every 12 hours) maintains steady pain control - Break-through pain: Add short-acting immediate-release medication (e.g., immediate-release morphine 15 mg as-needed) for pain escalations 3. **Multimodal approach**: Combine analgesics with different mechanisms - Example: Long-acting morphine + gabapentin (for neuropathic pain) + acetaminophen (for mild pain) + adjuvant antidepressant - This reduces opioid requirements and side effects 4. **Adjuvant medications are essential**, especially for neuropathic pain prevalent in diabetic patients: - **Anticonvulsants**: Gabapentin (Neurontin), pregabalin (Lyrica), carbamazepine — reduce nerve excitability; first-line for neuropathic pain - **Antidepressants**: Amitriptyline, duloxetine, venlafaxine — provide analgesia and address depression; tricyclic antidepressants particularly effective for neuropathic pain - **Topical agents**: Lidocaine patches, capsaicin cream for localized pain - **Other adjuvants**: NSAIDs for inflammatory pain, muscle relaxants for spasm-related pain, corticosteroids for pain with inflammation 5. **No arbitrary ceiling for opioids**: Unlike acute pain where we try to minimize opioid dose, in chronic severe pain, doses are titrated to effect without arbitrary maximum; there is no maximal dose of opioid if the patient has severe pain and is tolerating the medication 6. **Goal is functional improvement, not complete pain elimination**: - Realistic goal: Reduce pain enough to improve sleep, function, and quality of life - May not achieve 0/10 pain; goal may be 3–4/10 instead of 8/10, with improved function - Set specific functional goals with patient: "Walk 10 minutes daily," "Sleep 6 hours," "Return to light work" **Managing Opioid Tolerance in Chronic Pain** As discussed in the opioid section, tolerance develops with chronic use; the same dose provides less effect over time. This is **expected and appropriate to treat**: - **Recognition**: Patient reports pain has returned to previous level despite stable medication dose; requires increasing doses to maintain pain control - **Management**: Increase opioid dose as needed to maintain pain control; this is **not addiction**; this is appropriate treatment of tolerance - **Alternative approach**: Opioid rotation (switching to a different opioid) may sometimes restore effectiveness if tolerance to one opioid has developed - **Nursing role**: Document evidence of tolerance; communicate with provider for dose adjustment; reassure patient that increasing doses is normal and appropriate **Opioid-Induced Side Effects in Chronic Use** **Constipation** — As discussed, constipation is near-universal with chronic opioid use and does not diminish with tolerance. Proactive management: - Stimulant laxative from day one (senna, bisacodyl) - Bowel routine: same time daily, privacy, adequate time - Fiber and fluid intake - Activity/exercise - For severe constipation refractory to standard laxatives: naloxegol (peripheral opioid antagonist that blocks opioid effects in the gut without affecting central analgesia), or methylnaltrexone (also peripheral antagonist) **Sedation** — Tolerance often develops over days to weeks; may improve without dose reduction. If persistent: lower doses, switch opioids, add stimulant (methylphenidate), or adjust other CNS depressants **Cognitive Effects** — Some opioid users report "opioid fog," difficulty concentrating. Address with dose adjustment, optimize sleep, treat depression (which exacerbates cognitive symptoms), consider alternative medications **Sexual Dysfunction** — Opioids reduce sex hormone production; assess for impact on relationship and quality of life; consider hormone supplementation or medication adjustment **Hyperalgesia** — Paradoxically, some chronic opioid users develop increased pain sensitivity (opioid-induced hyperalgesia). Management: opioid rotation, dose reduction (sometimes), addition of NMDA antagonist (ketamine, methadone) **Non-Pharmacologic Management of Chronic Pain** **Multimodal non-drug interventions are as important as medication:** **Psychological and Cognitive-Behavioral Approaches:** - **Cognitive-behavioral therapy (CBT)**: Addresses pain-amplifying thoughts, teaches coping skills, improves mood - **Acceptance and Commitment Therapy (ACT)**: Focuses on accepting pain (not fighting it) and living meaningful life despite pain - **Mindfulness-based stress reduction**: Regular meditation practice - **Pain education**: Understanding pain physiology reduces fear and catastrophizing - **Relaxation and stress management**: Progressive muscle relaxation, diaphragmatic breathing - **Coping skill development**: Active coping (problem-solving, seeking support) more helpful than avoidance **Physical Interventions:** - **Exercise and physical therapy**: Gentle, graded increase in activity; prevents deconditioning; improves mood and endorphin production - Walking, swimming, low-impact activities - Tai chi, yoga - Strengthening and stretching - Regular program essential (not sporadic activity) - **Rehabilitation**: Helps restore function and return to work/meaningful activities - **Heat/cold therapy**: As tolerated - **TENS, acupuncture**: For selected patients **Sleep Optimization:** - Chronic pain severely disrupts sleep, creating vicious cycle: poor sleep → increased pain perception → increased opioid need - Interventions: Ensure analgesia is adequate before bed, sleep hygiene (cool, dark, quiet room), relaxation before bed, treatment of sleep disorders - If depression-related insomnia, antidepressant with sedating properties (amitriptyline, trazodone) **Social and Occupational Support:** - **Return to work**: Graded return to work if possible; improves mood, function, and self-esteem - **Social participation**: Encourage activities, social connection, hobbies - **Family education**: Help family understand chronic pain, avoid over-protection (which increases disability) - **Support groups**: Connection with others with similar pain conditions reduces isolation - **Vocational rehabilitation**: Job modifications, retraining if necessary **Spiritual and Existential Support:** - Meaning-making: Helping patient find meaning and purpose despite pain - Spiritual practices: Prayer, meditation, religious connection - Chaplain/spiritual advisor consultation - In the Filipino context, spiritual support often comes through family and faith community **Multidisciplinary Team Approach** Optimal chronic pain management involves coordination among: - **Pain physician or specialist**: Medication optimization - **Primary care physician**: Overall health, coordination - **Nurse/nursing team**: Patient education, monitoring, coordination, support - **Physical therapist**: Exercise, rehabilitation - **Mental health provider** (psychologist, psychiatrist): Depression, anxiety, CBT - **Occupational therapist**: Functional activities, work capacity - **Social worker**: Psychosocial support, resource navigation, disability services - **Chaplain/spiritual advisor**: Spiritual support In resource-limited Philippine settings, this full team may not be available; nurses often serve multiple roles and coordinate what services are accessible. **Managing Chronic Pain with History of Substance Use Disorder** Patients with opioid use disorder still develop chronic pain and deserve adequate pain management. Special considerations: - **Assessment**: Clarify whether the current pain is from a legitimate medical condition (yes, treat adequately) or primarily a symptom of active addiction (will not improve with opioid escalation) - **Coordination**: Involve addiction specialist; develop clear treatment plan with patient - **Medication contract**: May use written agreement outlining: - Specific pain medications and doses - Frequency of medication refills (avoid early refills) - Urine drug screens to verify medication adherence - Consequences of medication misuse - Boundaries and expectations - **Non-opioid preference**: Maximize non-opioid analgesics and adjuvants; use opioids at lowest effective dose if necessary - **Addiction treatment coordination**: Patient should be on medication-assisted treatment (methadone or buprenorphine maintenance) if active opioid addiction; pain medications are separate from addiction treatment medications - **Trust and therapeutic relationship**: Despite need for boundaries, maintain empathy and belief that patient deserves pain relief - **Dosing**: Do not undertreat pain; adequate treatment of pain actually reduces illicit opioid use (pain-driven use is common in addiction) **Chronic Pain and Mental Health** Depression and anxiety are extremely common (and often precede pain or develop as a consequence). Treatment must address both: - **Screen regularly**: Use standard screening tools (PHQ-9 for depression, GAD-7 for anxiety) - **Treat aggressively**: Untreated depression significantly worsens pain perception and disability - **Choose antidepressants wisely**: Dual-mechanism antidepressants (duloxetine, venlafaxine) provide both mood support and pain relief; tricyclic antidepressants (amitriptyline) provide pain relief and sleep - **Psychotherapy**: CBT, ACT, or supportive therapy essential - **Suicide risk**: Chronic pain increases suicide risk; screen regularly, especially if depression is present **End-of-Life and Palliative Care Perspective** In cancer pain and terminal illness, pain management goals shift: - **Aggressive opioid titration**: Titrate opioids to comfort without concern for overdose risk (comfort is the goal) - **Accept higher opioid doses**: No arbitrary ceiling; whatever dose is needed for comfort is appropriate - **Accept side effects if necessary**: Sedation may be acceptable to achieve comfort - **Psychological distress**: Address fears about death, pain, and existential concerns - **Spiritual support**: Critical component of end-of-life care - **Family involvement**: Family education and support essential - **Advance care planning**: Clarify goals, preferences, resuscitation status **The Undertreatment Crisis** A critical issue in chronic pain management is **widespread undertreatment** due to: - **Opioid phobia**: Healthcare providers' fear of causing addiction - **Regulatory concerns**: Strict opioid regulations in some settings - **Patient stigma**: Patients fear being seen as "addicts" - **Knowledge gaps**: Providers not understanding the difference between tolerance, dependence, and addiction **Nursing Role**: Advocate for adequate pain treatment; educate providers and patients about pain management principles; document inadequate pain control; support patients in asserting their right to pain relief. **Chronic Pain in Philippine Context** Specific challenges and considerations: - **High prevalence of diabetes and its complications**: Diabetic neuropathy is a major source of chronic neuropathic pain - **Limited access to pain specialists**: Most chronic pain is managed by primary care physicians; nurses often serve as primary educators and advocates - **Cost of medications**: Gabapentin, duloxetine, extended-release opioids may be expensive; cheaper alternatives sometimes used - **Cultural beliefs about pain**: Some cultural groups view pain as inevitable or spiritually meaningful; education needed - **Family-centered care**: Family involvement in pain management is strong; use this strength - **Limited mental health resources**: Depression accompanying chronic pain may go untreated; nurses should screen and advocate for services **Realistic Outcomes in Chronic Pain** Educate patients on realistic expectations: - Complete pain elimination is often not achievable - Goal is pain reduction (e.g., from 8/10 to 3/10) with improved function - Pain management is ongoing; no "cure" - Good response to treatment is possible with time and adjustment - Functional improvement (sleep, activity, mood) is the measure of success, not just pain numbers